Marker Therapeutics, Inc. Gains 34.44%

Marker Therapeutics, Inc. (MRKR:NASDAQ) shot up at $2.42, a gain of 34.4%. On Thu 18 Mar 21, MRKR:NASDAQ touched a New 2-Week Low of $1.8. The stock got featured on our News Catalysts scanner on Tue 16 Mar 21 at 05:18 PM in the 'PUBLIC OFFERING' category. From Thu 04 Mar 21, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue 09 Feb 21 at $3.77 with a volume of 2M+.

About Marker Therapeutics, Inc. (MRKR:NASDAQ)

TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.